These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38469407)

  • 1. Efficacy of polyethylene glycol loxenatide for type 2 diabetes mellitus patients: a systematic review and meta-analysis.
    Liu Y; Ma W; Fu H; Zhang Z; Yin Y; Wang Y; Liu W; Yu S; Zhang Z
    Front Pharmacol; 2024; 15():1235639. PubMed ID: 38469407
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of polyethylene glycol loxenatide in treating mild-to-moderate diabetic kidney disease in type 2 diabetes patients: a randomized, open-label, clinical trial.
    Cao Y; Cao S; Zhao J; Zhao J; Zhao Y; Liu Y
    Front Endocrinol (Lausanne); 2024; 15():1387993. PubMed ID: 39099671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term effect of polyethylene glycol loxenatide on weight loss in overweight or obese patients with type 2 diabetes: An open-label, parallel-arm, randomized, metformin-controlled trial.
    Cai H; Chen Q; Duan Y; Zhao Y; Zhang X
    Front Endocrinol (Lausanne); 2023; 14():1106868. PubMed ID: 36777344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Effects and Mechanisms of Polyethylene Glycol Loxenatide Against Hyperglycemia and Liver Injury in
    Zhang Y; Li Y; Zhao J; Wang C; Deng B; Zhang Q; Shi C
    Front Pharmacol; 2021; 12():781856. PubMed ID: 34938192
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of fecal microbiota transplantation in type 2 diabetes mellitus: a systematic review and meta-analysis.
    Yang Y; Yan J; Li S; Liu M; Han R; Wang Y; Wang Z; Wang D
    Endocrine; 2024 Apr; 84(1):48-62. PubMed ID: 38001323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial.
    Zhang S; Zhang C; Chen J; Deng F; Wu Z; Zhu D; Chen F; Duan Y; Zhao Y; Hou K
    Front Pharmacol; 2023; 14():1171399. PubMed ID: 37214446
    [No Abstract]   [Full Text] [Related]  

  • 7. Four kinds of traditional Chinese exercise therapy in the treatment of type 2 diabetes: a systematic review and network meta-analysis.
    Jia Y; Huang H; Yu Y; Jia H; Zhang Y
    Syst Rev; 2023 Dec; 12(1):231. PubMed ID: 38093392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Efficacy of Polyethylene Glycol Loxenatide in the Treatment of Obese or Overweight Patients with Type 2 Diabetes Mellitus.
    Song X; Yao M; Li Z; Guo S; Yin F; Li R
    J Coll Physicians Surg Pak; 2023 Dec; 33(12):1390-1394. PubMed ID: 38062594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review and meta-analysis of
    Pan L; Zhai X; Duan Z; Xu K; Liu G
    Front Pharmacol; 2022; 13():956313. PubMed ID: 36160405
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of polyethylene glycol loxenatide on cardiovascular outcomes in patients with type 2 diabetes: study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (BALANCE-3).
    Xie Y; Kuang J; Li Q; Hong T; Ji L; Kong Y; Duan Y; Chen L
    BMJ Open; 2023 May; 13(5):e069080. PubMed ID: 37192802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Tirzepatide on Weight, Lipid Metabolism and Blood Pressure in Overweight/Obese Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
    Lv X; Wang H; Chen C; Zhao Y; Li K; Wang Y; Wang L; Fu S; Liu J
    Diabetes Metab Syndr Obes; 2024; 17():701-714. PubMed ID: 38371390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Guo J; Chen H; Zhang X; Lou W; Zhang P; Qiu Y; Zhang C; Wang Y; Liu WJ
    Oxid Med Cell Longev; 2021; 2021():2074610. PubMed ID: 34956436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of dorzagliatin for type 2 diabetes mellitus: A meta-analysis and trial sequential analysis.
    Yu Y; Yang X; Tong K; Yin S; Hu G; Zhang F; Jiang P; Zhou M; Jian W
    Front Cardiovasc Med; 2022; 9():1041044. PubMed ID: 36505359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lifestyle interventions on cardiovascular risk factors among adults without impaired glucose tolerance or diabetes: A systematic review and meta-analysis.
    Zhang X; Devlin HM; Smith B; Imperatore G; Thomas W; Lobelo F; Ali MK; Norris K; Gruss S; Bardenheier B; Cho P; Garcia de Quevedo I; Mudaliar U; Jones CD; Durthaler JM; Saaddine J; Geiss LS; Gregg EW
    PLoS One; 2017; 12(5):e0176436. PubMed ID: 28493887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of medical plants from Zingiberaceae family on cardiovascular risk factors of type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.
    Zhang X; Chen X; Tang Y; Guan X; Deng J; Fan J
    J Food Biochem; 2022 Jul; 46(7):e14130. PubMed ID: 35332564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
    Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of Chinese herbal medicine as an add-on therapy for type 2 diabetes mellitus patients with carotid atherosclerosis: An updated meta-analysis of 27 randomized controlled trials.
    Zhang Z; Leng Y; Chen Z; Fu X; Liang Q; Peng X; Xie H; Gao H; Xie C
    Front Pharmacol; 2023; 14():1091718. PubMed ID: 37033624
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical efficacy of Huanglian Wendan decoction in treating type 2 diabetes mellitus: A systematic review and meta-analysis.
    Tian Y; Pang G; Pan L
    Medicine (Baltimore); 2023 Oct; 102(40):e35299. PubMed ID: 37800822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large dosage Huangqin (Scutellaria) and Huanglian (Rhizoma Coptidis) for T2DM: A protocol of systematic review and meta-analysis of randomized clinical trials.
    Huang X; Wang L; Yue R; Ding N; Yang H
    Medicine (Baltimore); 2020 Sep; 99(38):e22032. PubMed ID: 32957320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of probiotic and synbiotic supplementation on some cardiovascular risk factors among individuals with prediabetes and type 2 diabetes mellitus: A grade-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials.
    Naseri K; Saadati S; Yari Z; Asbaghi O; Hezaveh ZS; Mafi D; Hoseinian P; Ashtary-Larky D; Hekmatdoost A; de Courten B
    Pharmacol Res; 2022 Aug; 182():106288. PubMed ID: 35680009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.